Viewing StudyNCT00540072



Ignite Creation Date: 2024-05-05 @ 6:47 PM
Last Modification Date: 2024-10-26 @ 9:36 AM
Study NCT ID: NCT00540072
Status: COMPLETED
Last Update Posted: 2019-11-14
First Post: 2007-10-04

Brief Title: Study of Cidecin Daptomycin to Rocephin Ceftriaxone in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S Pneumoniae
Sponsor:
Organization: Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA